Showing Results for
- Academic Journals (27,770)
Search Results
- 27,770
Academic Journals
- 27,770
-
From:Pharmaceutical Technology Europe (Vol. 31, Issue 12) Peer-ReviewedNot since 1923 has the general public of the United Kingdom been sent to the polling stations in the month of December (1). However, the wish of the current UK prime minister, Boris Johnson, to hold a general election a...
-
From:Journal of Diabetes Nursing (Vol. 11, Issue 2) Peer-ReviewedThe publication of The Diabetes Information Jigsaw made for disappointing reading (Association of the British Pharmaceutical Industry et al, 2006). The report investigated information access for people with diabetes and...
-
From:Science (Vol. 307, Issue 5707) Peer-ReviewedFive trade groups representing pharmaceutical companies worldwide are urging members to release more information about clinical trials. However, some see the proposals as a way to stay ahead of legislation that could...
-
From:CMAJ: Canadian Medical Association Journal (Vol. 182, Issue 18) Peer-ReviewedThe Association of the British Pharmaceutical Industry has approved amendments to its code of practice that will require pharmaceutical companies to publicly disclose the amount of money they pay to doctors and other...
-
From:Applied Clinical Trials (Vol. 10, Issue 6) Peer-ReviewedABPI looks at ways to deal with bureaucratic inefficiencies and other problems that it says are hampering drug research in the British pharmaceutical industry. The "considerable bureaucracy and inefficiencies in the...
-
From:Applied Clinical Trials (Vol. 16, Issue 2) Peer-ReviewedFollowing a three-month suspension by the Association of the British Pharmaceutical Industry (ABPI) for breach of Code, Merck Sharp & Dohme's (Munich, Germany) ABPI membership has been reinstated....
-
From:Journal of Men's Health & Gender (Vol. 3, Issue 1) Peer-ReviewedThe Association of the British Pharmaceutical Industry (ABPI) has revised and updated its Code of Practice on pharmaceutical company interactions with healthcare professionals and other stakeholders. The 58-page...
-
From:Nursing Standard (Vol. 21, Issue 35) Peer-ReviewedSUMMARY A code of practice sets out how pharmaceutical companies can promote medicines to health professionals and give information about prescription-only medicines to the public. Keywords Nurse prescribers *...
-
From:Pharmaceutical Technology Europe (Vol. 23, Issue 5) Peer-ReviewedWhen Pfizer decided to close its R&D site in Sandwich attractiveness to the pharma industry. The site employs 2400 people and although Pfizer has stated that some positions will be transferred to other sites or to other...
-
From:Pharmaceutical Technology Europe (Vol. 24, Issue 6) Peer-ReviewedFor some time, stakeholders in the UK have been raising concern: about the country's attractiveness in terms of pharmaceutical investment. In particular, Pfizer's decision last year to exit a key site in Sandwich,...
-
From:Pharmaceutical Technology Europe (Vol. 22, Issue 10) Peer-ReviewedGSK Consumer Healthcare has been accused of breaching the Association of the British Pharmaceutical Industry's Code of Practice. The code covers the promotion of medicines, including journal and direct-mail...
-
From:Applied Clinical Trials (Vol. 15, Issue 9) Peer-Reviewed* In other Abbott news, the Association of the British Pharmaceutical Industry (London, UK) has reinstated Abbott Laboratories' (Abbott Park, IL) membership, which was suspended in February 2005 after the company...
-
From:Applied Clinical Trials (Vol. 15, Issue 11) Peer-ReviewedThe Association of the British Pharmaceutical Industry (ABPI) suspended Merck Sharpe & Dohme (Whitehouse Station, NJ) for at least three months after determining a management program developed by the company violated...
-
From:Applied Clinical Trials (Vol. 15, Issue 12) Peer-ReviewedAs a result of the UK's revised model clinical trials agreement, launched in partnership with the Department of Health, the NHS, the Association of the British Pharmaceutical Industry, and the BioIndustry Association,...
-
From:Applied Clinical Trials (Vol. 10, Issue 9) Peer-ReviewedThe Institute of Clinical Research (Maidenhead, UK) and the Association of the British Pharmaceutical Industry (London, UK) announced a new scheme to introduce qualifications for clinical research staff in the United...
-
From:MPR Obstetrician & Gynecologist Edition (Vol. 21, Issue 2) Peer-ReviewedBotox (onabotulinumtoxinA, from Allergan) has gained an indication for the prophylactic treatment of headaches in adults with chronic migraine. Studies showed patients treated with Botox experienced a significantly...
-
From:MPR Obstetrician & Gynecologist Edition (Vol. 22, Issue 1) Peer-ReviewedCompany: Ther-Rx Rx Pharmacologic class: Progestin Active ingredient: Hydroxyprogesterone caproate 250mg/mL; for deep IM inj; contains castor oil, benzyl benzoate, benzyl alcohol. Indication: To reduce risk of...
-
From:MPR Obstetrician & Gynecologist Edition (Vol. 20, Issue 3) Peer-ReviewedThe FDA has approved Plan B One-Step (levonorgestrel tablet, from Teva), a one-pill emergency contraceptive indicated to help prevent unintended pregnancy when taken within 72 hours after known or suspected unprotected...
-
From:MPR Obstetrician & Gynecologist Edition (Vol. 20, Issue 2) Peer-ReviewedCompany: Pfizer Rx Pharmacologic class: Muscarinic receptor antagonist Active ingredient: Fesoterodine fumarate 4mg, 8mg; ext-rel tabs. Indication: Overactive bladder (OAB) with urge urinary incontinence,...